Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 22 | 2023 | 934 | 1.900 |
Why?
|
Gene Expression Regulation, Neoplastic | 20 | 2021 | 8432 | 0.480 |
Why?
|
Breast Neoplasms | 23 | 2023 | 20824 | 0.440 |
Why?
|
Neoplasm Metastasis | 8 | 2020 | 4851 | 0.290 |
Why?
|
Immediate-Early Proteins | 2 | 2021 | 453 | 0.270 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3921 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-fos | 3 | 2021 | 575 | 0.250 |
Why?
|
Receptors, Androgen | 3 | 2018 | 1058 | 0.250 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2021 | 70 | 0.240 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2018 | 5172 | 0.210 |
Why?
|
Cell Line, Tumor | 21 | 2022 | 16690 | 0.200 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 52 | 0.190 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2015 | 713 | 0.180 |
Why?
|
Prostatic Neoplasms | 7 | 2023 | 11126 | 0.180 |
Why?
|
Wnt Proteins | 2 | 2015 | 721 | 0.180 |
Why?
|
Gene Expression Profiling | 11 | 2017 | 9445 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 295 | 0.170 |
Why?
|
Postmenopause | 1 | 2008 | 2460 | 0.170 |
Why?
|
Lipogenesis | 1 | 2020 | 212 | 0.170 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 360 | 0.150 |
Why?
|
Sequence Analysis, RNA | 8 | 2020 | 2012 | 0.150 |
Why?
|
Prolactin | 1 | 2019 | 669 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
Transforming Growth Factor beta | 2 | 2023 | 2007 | 0.140 |
Why?
|
beta-Globins | 1 | 2017 | 115 | 0.140 |
Why?
|
Mitosis | 1 | 2021 | 1208 | 0.140 |
Why?
|
DNA, Satellite | 1 | 2015 | 69 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2021 | 3554 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2017 | 1707 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2850 | 0.130 |
Why?
|
Centromere | 1 | 2015 | 220 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2021 | 634 | 0.120 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 193 | 0.120 |
Why?
|
Mice | 22 | 2023 | 81201 | 0.120 |
Why?
|
RNA | 3 | 2018 | 2749 | 0.110 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2015 | 798 | 0.110 |
Why?
|
Stromal Cells | 1 | 2019 | 1355 | 0.110 |
Why?
|
Receptor, Adenosine A2B | 1 | 2013 | 34 | 0.110 |
Why?
|
Signal Transduction | 10 | 2021 | 23404 | 0.110 |
Why?
|
Gene Knockdown Techniques | 4 | 2020 | 1656 | 0.100 |
Why?
|
Receptor, erbB-2 | 3 | 2017 | 2417 | 0.100 |
Why?
|
Animals | 27 | 2023 | 168768 | 0.100 |
Why?
|
Cell Proliferation | 4 | 2021 | 10483 | 0.100 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2015 | 828 | 0.100 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 670 | 0.100 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2011 | 129 | 0.100 |
Why?
|
RNA Interference | 4 | 2017 | 2890 | 0.090 |
Why?
|
Melanoma | 2 | 2020 | 5511 | 0.090 |
Why?
|
Neoplasm Transplantation | 4 | 2020 | 2086 | 0.090 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6313 | 0.090 |
Why?
|
Peptide Library | 1 | 2011 | 349 | 0.090 |
Why?
|
Proteomics | 2 | 2022 | 3638 | 0.090 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2012 | 415 | 0.090 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2009 | 82 | 0.090 |
Why?
|
Organic Cation Transport Proteins | 1 | 2009 | 52 | 0.090 |
Why?
|
Estrogen Receptor Modulators | 1 | 2009 | 61 | 0.090 |
Why?
|
Cell Cycle | 2 | 2015 | 2967 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2017 | 988 | 0.080 |
Why?
|
DNA Methylation | 1 | 2023 | 4285 | 0.080 |
Why?
|
Zinc Fingers | 1 | 2011 | 583 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1879 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2013 | 789 | 0.080 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2076 | 0.080 |
Why?
|
Neoplasms | 6 | 2017 | 21696 | 0.080 |
Why?
|
RNA, Small Interfering | 4 | 2020 | 3505 | 0.080 |
Why?
|
Transcription Factors | 3 | 2013 | 12207 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1295 | 0.080 |
Why?
|
Estrogen Receptor alpha | 3 | 2021 | 577 | 0.080 |
Why?
|
Chromatin | 3 | 2015 | 2933 | 0.080 |
Why?
|
Mice, Nude | 4 | 2017 | 3689 | 0.070 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1149 | 0.070 |
Why?
|
Single-Cell Analysis | 4 | 2020 | 2182 | 0.070 |
Why?
|
Genes, ras | 1 | 2009 | 690 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1377 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1741 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2725 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8861 | 0.070 |
Why?
|
Humans | 43 | 2023 | 744366 | 0.070 |
Why?
|
Repressor Proteins | 2 | 2015 | 3024 | 0.070 |
Why?
|
Pancreatic Neoplasms | 2 | 2014 | 5263 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1988 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2530 | 0.070 |
Why?
|
Cell Survival | 5 | 2017 | 5882 | 0.060 |
Why?
|
beta Catenin | 1 | 2010 | 1059 | 0.060 |
Why?
|
Fibroblasts | 2 | 2019 | 4162 | 0.060 |
Why?
|
Female | 25 | 2023 | 380193 | 0.060 |
Why?
|
Cell Division | 1 | 2011 | 4569 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18034 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6539 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2716 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2023 | 152 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2504 | 0.050 |
Why?
|
Valproic Acid | 1 | 2005 | 445 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2005 | 317 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2005 | 494 | 0.050 |
Why?
|
Up-Regulation | 3 | 2019 | 4222 | 0.050 |
Why?
|
Phenylacetates | 1 | 2021 | 114 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1342 | 0.050 |
Why?
|
Cell Line | 5 | 2015 | 16000 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3590 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5856 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2418 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13104 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3799 | 0.040 |
Why?
|
Cell Movement | 4 | 2014 | 5218 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 513 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3751 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 93 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2020 | 276 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2938 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 351 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 536 | 0.040 |
Why?
|
Indoles | 2 | 2021 | 1839 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5692 | 0.040 |
Why?
|
Cell Separation | 2 | 2014 | 1751 | 0.040 |
Why?
|
Mesoderm | 2 | 2013 | 686 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 675 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1524 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2021 | 550 | 0.040 |
Why?
|
Tamoxifen | 2 | 2014 | 981 | 0.040 |
Why?
|
Genomic Instability | 1 | 2021 | 695 | 0.040 |
Why?
|
Anoikis | 1 | 2017 | 49 | 0.040 |
Why?
|
Carboxy-Lyases | 1 | 2017 | 90 | 0.040 |
Why?
|
Peptide Synthases | 1 | 2017 | 80 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 320 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2017 | 190 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 612 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 210 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 292 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 601 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13693 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 6386 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3646 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2949 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2005 | 1916 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2023 | 2190 | 0.030 |
Why?
|
Osteonectin | 1 | 2014 | 34 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2019 | 2943 | 0.030 |
Why?
|
gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 74 | 0.030 |
Why?
|
Computational Biology | 1 | 2006 | 3519 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2017 | 709 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 2015 | 1375 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26388 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1782 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 502 | 0.030 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2013 | 48 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5867 | 0.030 |
Why?
|
Wnt2 Protein | 1 | 2012 | 28 | 0.030 |
Why?
|
Male | 10 | 2023 | 350115 | 0.030 |
Why?
|
Estradiol | 2 | 2011 | 2020 | 0.030 |
Why?
|
Contact Inhibition | 1 | 2012 | 48 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2110 | 0.030 |
Why?
|
Binding Sites | 1 | 2021 | 6111 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13286 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5181 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
Pseudopodia | 1 | 2013 | 172 | 0.030 |
Why?
|
Phenotype | 2 | 2023 | 16367 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 359 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4208 | 0.030 |
Why?
|
Wilms Tumor | 1 | 2015 | 373 | 0.030 |
Why?
|
DNA Damage | 2 | 2014 | 2432 | 0.030 |
Why?
|
Metabolomics | 1 | 2020 | 1485 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15078 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 440 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2012 | 399 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.030 |
Why?
|
Phthalazines | 1 | 2014 | 363 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2013 | 7721 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2013 | 3690 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4805 | 0.020 |
Why?
|
Poly T | 1 | 2010 | 5 | 0.020 |
Why?
|
Dacarbazine | 1 | 2014 | 566 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 261 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1084 | 0.020 |
Why?
|
Methylation | 1 | 2013 | 1106 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11366 | 0.020 |
Why?
|
RNA Splicing | 1 | 2015 | 908 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 561 | 0.020 |
Why?
|
Reverse Transcription | 1 | 2010 | 47 | 0.020 |
Why?
|
Phloroglucinol | 1 | 2010 | 6 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 376 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 955 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2011 | 409 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12262 | 0.020 |
Why?
|
Mutation | 3 | 2021 | 29786 | 0.020 |
Why?
|
Culture | 1 | 2014 | 633 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 907 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1276 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 769 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1379 | 0.020 |
Why?
|
Estrogens | 1 | 2017 | 1566 | 0.020 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2011 | 215 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1403 | 0.020 |
Why?
|
Genes, Lethal | 1 | 2009 | 242 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7294 | 0.020 |
Why?
|
Prognosis | 3 | 2017 | 29060 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2013 | 728 | 0.020 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2010 | 182 | 0.020 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2009 | 75 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1659 | 0.020 |
Why?
|
Microfluidics | 1 | 2014 | 662 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1783 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1856 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11525 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2011 | 853 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1142 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2010 | 677 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2011 | 10943 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2009 | 411 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2009 | 199 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 390 | 0.020 |
Why?
|
Apoptosis | 2 | 2017 | 9724 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2010 | 321 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3587 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 767 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1775 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1899 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1678 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12952 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 1683 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 13035 | 0.020 |
Why?
|
Clone Cells | 1 | 2009 | 1692 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5534 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1341 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1970 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4185 | 0.020 |
Why?
|
Metabolism | 1 | 2006 | 196 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3616 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2383 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19233 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4026 | 0.010 |
Why?
|
Plant Proteins | 1 | 2006 | 364 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2715 | 0.010 |
Why?
|
Plasmids | 1 | 2009 | 2308 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2043 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 1157 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 980 | 0.010 |
Why?
|
Models, Biological | 2 | 2011 | 9584 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2488 | 0.010 |
Why?
|
Oncogenes | 1 | 2009 | 1265 | 0.010 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 161 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 994 | 0.010 |
Why?
|
Xenopus | 1 | 2005 | 712 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 12073 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2006 | 2050 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4554 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9240 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2014 | 5023 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4740 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2478 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 213390 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
Alleles | 1 | 2009 | 6933 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4262 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3589 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53290 | 0.010 |
Why?
|
Rats | 1 | 2013 | 24252 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2716 | 0.010 |
Why?
|
Stem Cells | 1 | 2009 | 3567 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 21833 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.010 |
Why?
|
Aged | 1 | 2008 | 163288 | 0.010 |
Why?
|
Internet | 1 | 2006 | 3056 | 0.010 |
Why?
|
Adult | 1 | 2008 | 214052 | 0.010 |
Why?
|
Zebrafish | 1 | 2005 | 2996 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7882 | 0.010 |
Why?
|
Software | 1 | 2006 | 4441 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5101 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40075 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 19905 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 63107 | 0.000 |
Why?
|